Leaking of Chris Froome salbutamol case is a blow to cycling's reputation, says British Cycling CEO

British Cycling CEO Julie Harrington has criticised the leaking of Chris Froome’s Adverse Analytical Finding for salbutamol, believing it has damaged the reputations of Froome, British Cycling and the sport in general. She confirmed that Froome remains eligible for selection for the Great Britain national team until a verdict is reached.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1